These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 38999)

  • 21. Neuroleptic drugs and the central dopaminergic system. Antagonism between L-dopa and some butyrophenones on the EEG and motor effects elicited by stimulation of the mesencephalon in the rabbit.
    Florio V; Longo VG
    Neuropharmacology; 1971 Jan; 10(1):45-54. PubMed ID: 5569306
    [No Abstract]   [Full Text] [Related]  

  • 22. Changes in chlorpromazine induced CNS effects when associated with other neuroleptics and anxiolytics.
    Pérez-Raya MD; Risco S; Navarro C; Jimenez J; Cabo J
    Pharm Acta Helv; 1989; 64(5-6):146-50. PubMed ID: 2569203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in the sensitivity to apomorphine of dopamine receptors modulating dopamine and acetylcholine release after chronic treatment with bromocriptine or haloperidol.
    Cubeddu LX; Hoffmann IS; James MK; Niedzwiecki DM
    J Pharmacol Exp Ther; 1983 Sep; 226(3):680-5. PubMed ID: 6887008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Neuroleptic therapy of schizophrenia from pharmacological viewpoint].
    Stille G
    Schweiz Med Wochenschr; 1969 Nov; 99(46):1645-52 contd. PubMed ID: 4391348
    [No Abstract]   [Full Text] [Related]  

  • 25. Dopaminergic inhibition of sympathetic activity in the cat.
    Dóda M; György L
    Pol J Pharmacol Pharm; 1985; 37(3):397-404. PubMed ID: 4070081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurochemical changes associated with chronic administration of typical antipsychotics and its relationship with tardive dyskinesia.
    Bishnoi M; Chopra K; Kulkarni SK
    Methods Find Exp Clin Pharmacol; 2007 Apr; 29(3):211-6. PubMed ID: 17520104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antagonism of apomorphine-induced hyperthermia in MAOI-pretreated rabbits as a sensitive model of neuroleptic activity.
    Fjalland B
    Psychopharmacology (Berl); 1979 May; 63(2):119-23. PubMed ID: 38474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurophysiologic activity of chlorpromazine in clinical use.
    LEHMANN HE
    J Clin Exp Psychopathol; 1956; 17(2):129-41. PubMed ID: 13345875
    [No Abstract]   [Full Text] [Related]  

  • 29. Intraventricular infusions in acute and chronic rabbits. Application of the stereotaxic method of Monnier and Gangloff.
    Monnier M; Hatt AM
    Pflugers Arch; 1970; 317(3):268-77. PubMed ID: 4910211
    [No Abstract]   [Full Text] [Related]  

  • 30. Antagonism between dopaminergic and neuroleptic drugs. I. Acute administration.
    Bo P; Savoldi F; Tartara A
    Farmaco Sci; 1979 Jul; 34(7):621-7. PubMed ID: 38998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protective effect of Curcumin, the active principle of turmeric (Curcuma longa) in haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes in rat brain.
    Bishnoi M; Chopra K; Kulkarni SK
    Pharmacol Biochem Behav; 2008 Feb; 88(4):511-22. PubMed ID: 18022680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo microdialysis studies of striatal level of neurotransmitters after haloperidol and chlorpromazine administration.
    Kulkarni SK; Bishnoi M; Chopra K
    Indian J Exp Biol; 2009 Feb; 47(2):91-7. PubMed ID: 19374163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Iron modulates neuroleptic-induced effects related to the dopaminergic system.
    Ben-Shachar D; Livne E; Spanier I; Zuk R; Youdim MB
    Isr J Med Sci; 1993 Sep; 29(9):587-92. PubMed ID: 7901181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antagonism between dopaminergic and neuroleptic drugs. II. Chronic administration.
    Tartara A; Bo P; Savoldi F
    Farmaco Sci; 1979 Jul; 34(7):628-34. PubMed ID: 38999
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.